Docsity
Docsity

Prepare for your exams
Prepare for your exams

Study with the several resources on Docsity


Earn points to download
Earn points to download

Earn points by helping other students or get them with a premium plan


Guidelines and tips
Guidelines and tips

Life Science: Emerging Infectious Diseases and Antibiotic Resistance - A Human Approach - , Assignments of Biology

This document from la salle university, titled 'the killers all around' by m.d. Lemonick et al., published in time magazine in 1994, discusses the emergence and re-emergence of infectious diseases in the us, mechanisms by which microbes make humans sick, antibiotic resistance, and the differences between viruses and bacteria. The document also covers the evolution of microbes, the impact of human behavior on antibiotic resistance, and the role of vaccines and antibiotics in dealing with viral and bacterial diseases.

Typology: Assignments

Pre 2010

Uploaded on 08/19/2009

koofers-user-vxj
koofers-user-vxj 🇺🇸

10 documents

1 / 1

Toggle sidebar

This page cannot be seen from the preview

Don't miss anything!

bg1
Bio 158: Life Science – A Human Approach La Salle University
"The Killers All Around"
by M.D. Lemonick et al.
Time 144(11):62-69. Sept. 12, 1994
Available on line at http://www.time.com/time/magazine/article/0,9171,981430-1,00.html
Link available on course web page: Resources and Assignments (http://alpha.lasalle.edu/~mcphilli/158assignments.htm
Questions for Guided Reading
1. What are some of the infectious diseases that are currently emerging or re-emerging in the United States?
2. Describe some general mechanisms by which microbes make humans sick.
3. Forty years ago we could routinely treat diseases such as cholera, tuberculosis, staph infections and strep infections with
antibiotics. Now the same treatments are often ineffective. Why?
4. How did Jim Henson (of Muppets fame) die?
5. How do bacteria become resistant to antibiotics?
6. Why do bacteria evolve much faster than humans?
7. Human behavior often increases the rate at which bacterial populations gain resistance to antibiotics. Explain.
8. Which is the better mechanism to deal with viral diseases: antibiotics or vaccines? Explain.
9. What is the difference between a virus and a bacterium?
10. The AIDS virus (HIV) is more of an evolutionary success than the Ebola virus. Explain.
11. How do environmental changes help microbes move from animals to humans?
12. What measures can be taken to reduce the risk to humans from infectious diseases?

Partial preview of the text

Download Life Science: Emerging Infectious Diseases and Antibiotic Resistance - A Human Approach - and more Assignments Biology in PDF only on Docsity!

Bio 158: Life Science – A Human Approach La Salle University

"The Killers All Around"

by M.D. Lemonick et al.

Time 144(11):62-69. Sept. 12, 1994

Available on line at http://www.time.com/time/magazine/article/0,9171,981430-1,00.html

Link available on course web page: Resources and Assignments (http://alpha.lasalle.edu/~mcphilli/158assignments.htm

Questions for Guided Reading

  1. What are some of the infectious diseases that are currently emerging or re-emerging in the United States?
  2. Describe some general mechanisms by which microbes make humans sick.
  3. Forty years ago we could routinely treat diseases such as cholera, tuberculosis, staph infections and strep infections with antibiotics. Now the same treatments are often ineffective. Why?
  4. How did Jim Henson (of Muppets fame) die?
  5. How do bacteria become resistant to antibiotics?
  6. Why do bacteria evolve much faster than humans?
  7. Human behavior often increases the rate at which bacterial populations gain resistance to antibiotics. Explain.
  8. Which is the better mechanism to deal with viral diseases: antibiotics or vaccines? Explain.
  9. What is the difference between a virus and a bacterium?
  10. The AIDS virus (HIV) is more of an evolutionary success than the Ebola virus. Explain.
  11. How do environmental changes help microbes move from animals to humans?
  12. What measures can be taken to reduce the risk to humans from infectious diseases?